尺神经病是一种更常见的诊断单神经病;尽管如此,明确的手术治疗策略尚未得到广泛认同.在这项研究中,我们系统地回顾了文献,并评估了接受原位减压的神经炎或神经病患者的恢复到游戏或活动的结果,皮下转位,或尺神经肌下转位。我们假设,在没有尺侧副韧带(UCL)病理的情况下,尺神经移位或减压将具有很高的活动恢复率。相关研究是使用PubMed从1975年到2023年进行的,学术搜索完成,CINAHL(护理和相关健康文献累积指数),MEDLINE,和SPORTDiscus。纳入了有关孤立的尺神经移位或减压治疗尺神经炎后恢复游戏或活动结果的文章。排除评估合并UCL损伤或翻修手术的患者的研究。共有12项研究符合纳入标准,从1977年到2021年。在所有研究中,共有358名患者报告恢复了游戏或活动状态,平均年龄为27.2岁(范围,11-75).成功回归发挥,活动,303例患者(84.6%)报告有工作.接受换位的患者,皮下(n=232)和肌肉下(n=20),回报率分别为87.9%和95%,分别。接受原位减压的患者(n=106)的回报率为75.5%。这项系统评价发现,在没有合并UCL病理的情况下,尺神经移位或减压后,活动率恢复为84.6%。总的来说,尺神经转位或减压可以很好地恢复活动率,并且有适当的适应症和手术技术可能会成功恢复。
Ulnar neuropathy is one of the more commonly diagnosed mononeuropathies; despite this, a definitive surgical treatment strategy has not been widely agreed upon. In this study, we systematically review the literature and assess return to play or activity outcomes in patients with neuritis or neuropathy undergoing in situ decompression, subcutaneous transposition, or submuscular
transposition of the ulnar nerve. We hypothesized that ulnar nerve transposition or decompression in the absence of concomitant ulnar collateral ligament (UCL) pathology would have a high rate of return to activity. Relevant studies were generated from 1975 to 2023 using PubMed, Academic Search Complete, CINAHL (Cumulative Index to Nursing and Allied Health Literature), MEDLINE, and SPORTDiscus. Articles reporting on return to play or activity outcomes following isolated ulnar nerve
transposition or decompression for ulnar neuritis were included. Studies evaluating patients with concomitant UCL injury or revision surgery were excluded. A total of 12 studies met the inclusion criteria, ranging from 1977 to 2021. There were a total of 358 patients with a reported return to play or activity status across all studies with an average age of 27.2 years (range, 11-75). Successful return to play, activity, or work was reported in 303 patients (84.6%). Patients undergoing
transposition, subcutaneous (n = 232) and submuscular (n = 20), had return rates of 87.9% and 95%, respectively. Patients undergoing in situ decompression (n = 106) had return rates of 75.5%. This systematic review found an 84.6% return to activity rate following ulnar nerve
transposition or decompression in the absence of concomitant UCL pathology. Overall,
transposition or decompression of the ulnar nerve provides a favorable return to activity rates and with appropriate indications and surgical technique will likely yield a successful return.